DNA and RNA Sample Preparation Market Size, Share, and Growth Forecast for 2025 - 2032

DNA and RNA Sample Preparation Market Size and Trends

The global DNA and RNA sample preparation market size is anticipated to rise from US$ 2.12 Bn in 2025 to US$ 3.11 Bn by 2032. It is projected to witness a CAGR of 5.7% from 2025 to 2032.

As per Persistence Market Research (PMR), rise in infectious diseases and the introduction of new products are predicted to fuel growth in the global market for DNA and RNA sample processing. DNA and RNA preparation is necessary for the diagnosis of illnesses, including hepatitis, pneumonia, and AIDS.

• According to the National Center for Health Statistics from National Ambulatory Medical Care Survey, in 2020, nearly 765,000 emergency department visits resulted in hospital admissions due to diagnosis of infectious and parasitic diseases.
• Globally, 300 to 500 million cases of malaria, 333 million cases of sexually transmitted diseases, 33 million cases of HIV, 14 million tuberculosis cases, and 3 to 5 million cases of cholera are among the most prevalent. 

Key Industry Highlights

• Growing cancer research initiatives necessitate the efficient processing of high-quality nucleic acid samples.
• The efficiency of sample preparation is being enhanced by technical developments in sequencing platforms.
• The prevalence of personalized medicine is boosting demand for genomic analysis.
• Academic institutions are extending their research in molecular biology, necessitating solutions for DNA/RNA preparation.
• Emphasis on pharmaceutical research and development has resulted in a spike in the demand for sample preparation.

Global Market Attributes	Key Insights
DNA and RNA Sample Preparation Market Size (2025E)	US$ 2.12 Bn
Market Value Forecast (2032F)	US$ 3.11 Bn
Projected Growth (CAGR 2025 to 2032)	5.7%
Historical Market Growth (CAGR 2019 to 2024)	4.6%

Historical Growth and Course Ahead

Prevalence of Infectious Diseases Boosted Medical Sampling Amid the Pandemic

The global DNA and RNA sample preparation industry witnessed a CAGR of 4.6% in the historical period between 2019 and 2024. The World Health Organization (WHO) reports a rising global burden of infectious diseases, including TB, which is the 13th leading cause of death and the second leading infectious killer after COVID-19. For example,

• In 2021, an estimated 10.6 million people fell ill with TB, with only 1 in 3 people with drug-resistant TB receiving treatment.
• The Indian Council of Medical Research certified an RNA-based COVID-19 diagnostic kit for commercial use in July 2020, while Purigen Biosystems Inc. introduced the Ionic Cells to Pure DNA Low Input Kit in October 2020 for researchers dealing with constrained biological material.

Innovation in Diagnosis and Treatments to Augment Sales through 2032

In the estimated timeframe from 2025 to 2032, the global market for DNA and RNA sample preparations is likely to showcase a CAGR of 5.7%. Key market players are focusing on obtaining approvals for newer diagnostic kits to expedite the diagnosis and treatment of infectious diseases due to the increasing burden. For example,

• In November 2022, Indian biotechnology company Mylab Discovery Solutions received approval from CDSCO and ICMR for its product PathoDetect, a Real-Time RT-PCR-based kit for detecting multiple drug resistance to rifampicin and isoniazid in a single test, crucial for rapid diagnosis and treatment of infectious diseases.

Market Dynamics

Growth Drivers

High Speed of Nucleic Acid Sample Preparation Shows Prospects   

DNA-RNA sample preparation has been improved by lower sample volumes, complicated sample types, and faster preparation. Production may be increased by automating preparation activities.

Vacuum purification and single-use centrifuge methods can be used with multi-well plate systems, such as GE Healthcare's illustraTM RNAspin 96 RNA Isolation Kit, to enhance sample throughput and extraction times.

• High PCR efficiency, sensitivity, reproducibility, and durability are provided by a proprietary solution from InnoGenomics Technologies that addresses multiplexing difficulties with REs.

The InnoXtract technology, which extracts DNA from bone samples, was introduced by the business. Manufacturers of DNA and RNA sample processing will have profitable growth prospects in the future due to such considerations.

Market Restraining Factors

Lack of Theoretical Knowledge in Sample Processing Slows Down Market Growth for DNA and RNA Analysis

Sampling proteins and RNA is a complex task because of their sensitivity. This process requires skilled personnel and careful monitoring. Mistakes in sampling can lead to wasted time and effort and may necessitate repeating processes.

With the increasing number of companies in the sample preparation industry, along with a wider range of product specifications and varying value propositions, customers often find it challenging to choose the best option. Changes in processes and techniques can be difficult for newcomers or those with limited theoretical knowledge, which may hinder the growth of the DNA and RNA sample processing market.

Key Market Opportunities

Rising Cancer Research Initiatives to Provide Novel Development Prospects

As more money is invested in molecular diagnostics and personalized medicine, the growing field of cancer research is driving demand for high-quality nucleic acid sample processing. Researchers need precise and contamination-free samples for genetic and biomarker investigations. Diagnostic centers are predicted to dominate the market, holding a 34.2% share in 2025, due to the increasing number of patient visits. For example,

• In October 2023, Qiagen launched an advanced RNA extraction kit optimized for tumor biopsy samples, improving the accuracy of cancer diagnostics.
• In November 2023, Thermo Fisher Scientific expanded its nucleic acid purification solutions, enhancing workflow efficiency in oncology research labs.

Companies are investing in automation, AI-driven sample processing, and NGS technologies owing to the expected 47% rise in the prevalence of cancer worldwide by 2040, which would need a boom in high-quality DNA and RNA separation techniques.

DNA and RNA Sample Preparation Market Insights and Trends

Product Insights

Convenience and User-friendliness to Push Growth of DNA and RNA Sampling Kits

In 2025, the kits segment is projected to hold a 47.2% share of the global DNA and RNA sample preparation industry, driven by high demand for genetic testing, diagnostics, and research applications. Kits are widely used for DNA and RNA isolation, purification, and quantification, offering convenience, accuracy, and scalability for laboratories and healthcare facilities. For example,

• In October 2023, Qiagen launched a high-throughput nucleic acid extraction kit, improving sample processing efficiency.
• In November 2023, Promega Corporation introduced an RNA purification kit, optimized for liquid biopsy samples in cancer research.

Pre-packaged nucleic acid extraction kits dominate the market due to increasing genomics and personalized medicine research and development activities, ensuring consistent results and ease of use in diagnostic and research settings.

Application Insights

Research in Clinical Testing Presents Growth Avenues in Life Sciences   

In 2025, the clinical testing segment is likely to hold a 34.9% share of the global DNA and RNA sample preparation market, driven by rising demand for genetic testing, infectious disease diagnosis, and personalized medicine. Increasing prevalence of cancer and rare genetic disorders has boosted the need for high-precision nucleic acid sample preparation in clinical settings. For example,

• In October 2023, Roche Diagnostics introduced an automated DNA extraction system to enhance clinical genomics workflows.
• In November 2023, Illumina expanded its RNA-based diagnostics, improving early cancer detection.

As clinical applications continue expanding, developments in molecular diagnostics and next-generation sequencing (NGS) are driving market growth.

Regional Insights and Trends

North America to See Steady Growth Amid Increasing Biotechnology Investments

In 2025, North America is set to hold a 35.1% share of the global DNA and RNA sample preparation market, driven by high chronic disease prevalence, strong biotechnology investments, and advanced research infrastructure. North America, a leader in genetic research and molecular diagnostics, is set to experience continued market growth due to government funding and key market players, with a forecast CAGR of 5.2% from 2025 to 2032. For instance,

• In October 2023, Agilent Technologies launched an automated DNA extraction platform to enhance precision diagnostics and genomic research.
• In November 2023, Bio-Rad Laboratories expanded its RNA sequencing prep kits, improving cancer and infectious disease research.

Academic Institutions in Europe to Broaden the Field of Molecular Biology Research

Europe is projected to hold a market share of 28.6% in the DNA and RNA sample preparation market in 2025, fueled by academic molecular biology research. With a projected CAGR of 4.9% from 2025 to 2032, Europe is bolstering its position in life sciences research.

Governments are increasing funding for genomics and biotechnology, leading to a higher demand for advanced DNA/RNA preparation solutions. For example,

• In October 2023, Qiagen partnered with the University of Oxford to develop new RNA sequencing techniques, improving gene expression research.
• In November 2023, Merck KGaA expanded its molecular biology reagent production in Germany, making DNA/RNA extraction more efficient.

Rising Investments in Genetic Research in Asia Pacific to Offer Lucrative Opportunities 

In 2025, Asia Pacific is projected to hold a 24.7% share of the global DNA and RNA sample preparation market, driven by rapid healthcare infrastructure development, expansion of biotech companies, and rising hematological disease cases. Asia Pacific is likely to record a CAGR of 6.1% from 2025 to 2032, due to innovations in molecular biology and precision healthcare. The region's growing investments in genetic research and molecular diagnostics are fueling market growth.

• In October 2023, Takara Bio expanded its RNA extraction kit production in Japan, enhancing precision medicine research.
• In November 2023, BGI Genomics launched a high-throughput DNA sequencing platform in China, improving genetic disorder diagnostics.

DNA and RNA Sample Preparation Market Competitive Landscape

The global DNA and RNA sample processing market is changing quickly, and businesses are continually looking for ways to improve and enhance their goods and services. In light of the growing need for sophisticated sample preparation solutions, they are concentrating on growing their clientele and gaining a competitive edge.

The growing interest has sparked the industry's notable expansion as well as increased rivalry among key participants. These have spurred innovation and compelled companies to keep improving their products to satisfy the shifting demands of labs and researchers throughout the globe.

Key Industry Developments

• In December 2024, QIAGEN installed over 1,000 EZ2 Connect automated sample preparation instruments, enhancing precision and reproducibility in nucleic acid purification, reducing hands-on time, and increasing throughput.
• In August 2024, Beckman Coulter Life Sciences and Illumina introduced the TruSight Oncology 500 DNA/RNA application, an automated solution for comprehensive genomic profiling of tumor samples.
• In May 2024, QIAGEN introduced a multimodal DNA/RNA Library Kit that facilitates genomic profiling and multiomic research, streamlining library preparation for next-generation sequencing and promoting precision medicine.
• In May 2024, Integrated DNA Technologies and Molecular Health announced a multi-year cooperation to improve cancer research, lab efficiency, and NGS data interpretation.
• In February 2024, Complete Genomics and seqWell partnered to expand library preparation options, ensuring compatibility with Next-Gen sequencing and automation portfolios.
• In January 2024, Alpha Laboratories and ProtonDx introduced SmartLidTM, a magnetic key and lid device that streamlines essential processes for effective viral DNA/RNA extraction.

DNA and RNA Sample Preparation Market Report Scope

Report Attributes	Details
Historical Data/Actuals	2019 - 2024
Forecast Period	2025 - 2032
Market Analysis Units	Value: US$ Bn/Mn, Volume: As applicable
Geographical Coverage	North America Europe East Asia South Asia and Oceania Middle East and Africa Latin America
Segmental Coverage	Product Application End User Region
Competitive Analysis	Thermo Fisher Scientific Inc. Isogen Lifescience B.V. MP Biomedicals Minerva Biolabs GmbH QIAGEN Bio-Rad Laboratories, Inc Merck KGaA Agilent Technologies, Inc. c-LEcta GmbH Beckman Coulter, Inc. Bioresearch Technologies Promega Corporation Illumina, Inc. Aurora Biomed Inc. Hygiena LLC Tecan Trading AG MACHEREY-NAGEL GmbH & Co. KG Ahlstrom Nanodigmbio (Nanjing) Biotechnology Co., Ltd. Bionano Genomics, Inc. Revvity F. Hoffmann-La Roche Ltd New England Biolabs
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Pricing Analysis & Technology Roadmap Future Opportunities and Revenue Pockets Industry Market Analysis Tools
Customization and Pricing	Available upon request

DNA and RNA Sample Preparation Market Segmentation

By Product

• Workstations
• Kits
  • DNA Sample Preparation      
  • RNA Sample Preparation
• Reagent and Consumables

By Application

• Clinical Testing
• Diagnostic Testing
• Research Application
• Others

By End User

• Hospitals
• Diagnostic Centers
• Forensic Science Laboratories
• Academic and Research Institutions
• Others

By Region

• North America
• Europe
• East Asia
• South Asia and Oceania
• Middle East and Africa
• Latin America

To know more about delivery timeline for this report Contact Sales